In a recent article, hospital leaders said that CMS’ price transparency rules puts them at a competitive disadvantage — a justification several readers argued is not persuasive in a Jan. 11 Wall Street Journal opinion piece.
Read the full post on Becker's Hospital Review - Healthcare News
